Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.

NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is scheduled to resume on Thursday, May 28, 2020, at …
(Orginal – Story lesen…)